We investigated the release of endothelium-derived relaxing factor (EDRF) in response to serotonin and histamine in the human internal mammary artery and saphenous vein. The arteries and veins were obtained intraoperatively and were suspended in organ chambers to record isometric tension.
The blood vessel wall has protective mechanisms preventing the occurrence of platelet adhesion, platelet aggregation, and vasospasm under normal conditions.1,4-6The endothelium appears to play an instrumental role by releasing endothelium-derived relaxing factor (EDRF), which evokes relaxation of vascular smooth muscle and inhibition of platelet function.," '2-16 Ischemia and vascular occlusion occur frequently in some but rarely in other vascular beds of the circulation. Similarly, arterial coronary artery bypass grafts have a higher patency and lower patient mortality than venous grafts. '7-20 We previously showed that endothelium-dependent relaxations to acetylcholine, ADP, and thrombin are larger in human internal mammary arteries than in saphenous veins of patients undergoing coronary artery bypass surgery. 21 This study was performed to investigate whether or not platelet-derived products such as serotonin and histamine evoke different endothelium-dependent responses in human artery and veins used in bypass grafting and whether or not EDRF mediates the response. Different endothelium-dependent responses to plateletderived products and to histamine may be important for graft function and patency.
Methods

Protocol
Internal mammary arteries and veins and saphenous veins were harvested intraoperatively from patients undergoing coronary artery bypass surgery for coronary artery disease. The internal mammary artery and vein were dissected free, leaving the vessels in their original surrounding on a pedicle of internal thoracic fascia as previously described. 21 The experiments were performed in rings of the internal mammary artery and veins and in the saphenous vein with and without endothelium. The blood vessels were dissected free and cleaned of adherent connective tissue under a dissection microscope (Wild and Leitz, Zurich, Switzerland) as reported. 21 The preparations were then cut into rings (about 5 mm in length) and placed in cold modified Krebs-Ringer bicarbonate solution of the following millimolar composition: NaCl 118, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0, edetate calcium disodium 0.026, and glucose 11.1 (control solution). The presence or absence of functional vascular endothelium was confirmed in each ring at the beginning of the experiment by the presence or absence of a relaxation to acetylcholine (10-6 M) or bradykinin (10-6 M) . In internal mammary artery rings with endothelium, the relaxation to acetylcholine averaged 90±4%; in saphenous veins with endothelium, the relaxation to bradykinin was 54+4%. The endothelium was removed by intraluminal perfusion of the vascular segment with 0.5% 3-[(3-cholamidopropyl)dimethylammonio]1-propanesulfonate (CHAPS) for 60 seconds from rings of the internal mammary artery and for 90 seconds from rings of the saphenous vein. 22 The rings were suspended between two stirrups in organ chambers filled with 25 ml control solution (370 C) aerated with 95% 02-5% CO2. The rings were connected to force transducers (Statham Universal UC2), and changes in isometric force were recorded. The ring preparations were progressively stretched and exposed to norepinephrine (3 x 10`M) at each level of stretch until the optimal point of the length-tension relation was reached. 21 Thereafter, the rings were allowed to equilibrate for 45 Figures 1 and 2 ). In rings with endothelium, the IC50 value of histamine averaged 6.5+0.2, and the maximal relaxation averaged 70±5% (Table 1) . Meclofenamate (10-5 M), used to block the production of prostacyclin, did not affect the relaxations evoked by histamine (ED50, 6.3 ±0.2; maximal relaxation, 62+9%; n=6). In rings with endothelium that were previously relaxed by acetylcholine (10-6 M, 87±6%), pretreatment with methylene blue (10-5 M), used to block the production of cyclic GMP, completely prevented the relaxations but not the contractions induced by histamine (n =3). Human hemoglobin (10-5 M) added after maximal relaxation to histamine completely reversed the response (n=3, Figure 1 ). In internal mammary artery rings with endothelium, the H1-histaminergic receptor antagonist chlorpheniramine (10-5 M) inhibited relaxations to histamine ( Figure 3 ). The H2-histaminergic blocker Histamine (-logM) cimetidine (10-5 M) did not affect endotheliumdependent relaxations but did augment the contractile response occurring at the highest concentration of histamine (10-5 M). Combined H1-and H2-histaminergic blockade prevented relaxations induced by histamine. In saphenous veins with endothelium contracted by norepinephrine (10-7 M) that was previously relaxed by bradykinin (10 6 M), histamine failed to induce significant relaxations (maximal relaxation, 0-24%) but did evoke pronounced contractions at higher concentrations ( Figure 2 ). The maximal contraction evoked by histamine was enhanced in rings with (239±33%) compared with those without endothelium (150±17%, n=6, p<0.05, Figure 2 ). In contrast, contractions to 100 mM KCI did not differ between saphenous vein rings with and without endothelium (7.2±0.3 and 7.1±1 g, respectively, Table 2 ). Similarly, the contractions to a halfmaximal concentration of norepinephrine (10`' M) were identical in preparations with and without endothelium (2.7+0.19 and 2.9±0.19 g, respectively, NS).
In internal mammary veins, in contrast to the saphenous veins, histamine induced endotheliumdependent relaxations to an extent similar (77±6%) and a sensitivity comparable (IC50, 6.8±0.1) to that of the mammary artery (n=5, data not shown). In saphenous veins with endothelium, the H1-histaminergic receptor antagonist chlorpheniramine (10-5 M) completely inhibited contractions induced by histamine (Figure 4) . In contrast, H2-histaminergic blockade with cimetidine (10-5 M) did not affect the response. Accordingly, combined H1-and H2-histaminergic blockade evoked effects similar to those of HI1-histaminergic blockade alone.
Endothelium-independent responses. In internal mammary artery rings without endothelium, histamine evoked only contractions at higher concentrations ( Figure 2) . In rings treated with the HI- 5-hydroxytryptamine (-ogMl histaminergic antagonist chlorpheniramine, contractions induced by the amine were inhibited, and weak relaxations were unmasked (Figure 3 ).
The addition of the H2-histaminergic blocker cimetidine under these conditions completely blocked these relaxations. In saphenous veins without endothelium, histamine evoked contractions similar to those in arterial rings without endothelium (Figure 2 ). The effects of histaminergic blockers were comparable to those observed in the mammary artery without endothelium ( Figure 4 ).
Serotonin
Endothelium-dependent responses. In internal mammary artery rings with endothelium contracted by prostaglandin F2a, serotonin failed to evoke endothelium-dependent relaxations in the presence or absence of ketanserin (10 6 M) to inhibit S2-serotonergic receptors on vascular smooth muscle cells ( Figure 5, n=3 ).
In unstimulated mammary artery rings with endothelium, serotonin (10 8 to 10-4 M) evoked concentration-dependent contractions (n=6, Figure  6 ). The maximal response averaged 50±6% of the contraction to 100 mM KCl, and the EC30 value averaged 6.1±0.1 (Table 2) . Endothelium removal did not significantly affect the sensitivity to the monoamine (EC30 value, 6 .3±0.2), but removal did slightly enhance the maximal response (64±5%, n=6, p<0.034).
In the saphenous vein with endothelium, serotonin (3 x 10`to 10-4 M) evoked contractions that were not affected by endothelium removal (n = 6 and n=5, respectively, Figure 6 ). The EC30 value (7.5±0.1) and the maximal response (107±15%) to the monoamine were markedly greater in the vein compared with that of the artery ( Endothelium-dependent relaxations to histamine in the mammary artery were almost as pronounced as those previously described for acetylcholine despite direct vasoconstrictor effects of the amine. [34] [35] [36] In the pig, histamine elicits coronary vasospasm at the site of previous endothelial denudation. 37 Thus, the release of EDRF in response to histamine in the mammary artery may protect against vasospasm and, in turn, local platelet activation. Platelets can also release histamine.32,38 In the porcine pulmonary artery, platelet-derived histamine contributes to endothelium-dependent relaxations induced by aggregating platelets (personal communication with T. Sellers and P.M. Vanhoutte).
In contrast to effects in the mammary artery, the contractile effects of histamine predominate and are enhanced in the presence of the endothelium in the saphenous vein. Atherosclerosis, which appears to develop more frequently in venous than in arterial grafts,18,39 may further augment that response. Indeed, human atherosclerotic coronary arteries /-\ have an increased histamine content and exhibit enhanced contractions to the monoamine.10 In contrast to venous grafts, the mammary artery remains remarkably free of atherosclerotic changes both as a native vessel and as a graft. [17] [18] [19] [20] 40 In contrast to effects in the canine and porcine coronary artery,41,42 serotonin did not evoke endothelium-dependent relaxations in the mammary artery in the presence or absence of ketanserin to block excitatory S2-serotonergic receptors on vascular smooth muscle cells. Similar results have been obtained in the human coronary and renal arteries, indicating that the human vascular endothelium does not express serotonergic receptors linked to the release of EDRF.4344 However, in the mammary artery, but not in the saphenous vein, endothelial cells slightly inhibited the maximal contraction to serotonin. This would indicate that basal release of EDRF modulates vascular tone in the artery but is weak or absent in the vein. [23] [24] [25] 45 In addition, the contractions to the monoamine were markedly enhanced in the vein compared with those in the artery. This contrasts with the only minimally enhanced sensitivity of the saphenous vein to norepinephrine. 21 Serotonin is a major component of circulating platelets released during activation and aggregation.13,5-7,44,46 Marked contractions to the monoamine, as occur in the saphenous vein, would reduce local blood flow at sites where platelets are activated and would favor thrombus formation. Histamine, which is elevated after coronary thrombosis,47 would further evoke contractions and decrease local blood flow in venous grafts. In contrast to results in the saphenous vein, the sensitivity and potency of serotonin were much lower in the mammary artery, and the endothelium further inhibited the contractions. The release of EDRF in response to other plateletderived products such as ADP and thrombin21 and to histamine in arterial grafts would prevent vasospasm48'49 and inhibit platelet function,15,16 thereby limiting and flushing away a nascent thrombus and maintaining local blood flow. In contrast, the reduced release of EDRF and the enhanced contractions to serotonin in venous grafts would favor vasospasm and thrombus formation. Potent contractions of implanted venous grafts have occurred in vivo48 and in vitro.50 Because platelets have been implicated in coronary artery bypass occlusion,51 the effective release of EDRF in the mammary artery may be important for better function and higher patency of arterial compared with venous grafts. [17] [18] [19] [20] 
